IHS Chemical Week

People & Business :: Companies

FDA Issues Import Alert on Apotex Products

4:42 AM MDT | September 10, 2009 | Deepti Ramesh

Generic pharmaceutical company Apotex (Toronto) says the U.S. FDA has issued an import alert that applies to products manufactured at two of Apotex’s facilities in Canada. The alert relates to observations made following routine audits for products meant for the U.S. market, Apotex says. The import alert is following an inspection of the facilities in late 2008 which found deviations from U.S. cGMP (current good manufacturing practices), and a warning letter sent to the company in June 20009, press reports say. “We are actively working with the FDA to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa